Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

No limit: NewLimit, the longevity startup founded by Coinbase CEO Brian Armstrong, raised a $130 million Series B led by Kleiner Perkins to develop age-reversing therapies.

NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...